Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05779072
Other study ID # MIST-402
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2019
Est. completion date March 1, 2021

Study information

Verified date March 2023
Source Coopervision, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effect of ceasing treatment with dual focus soft contact lenses.


Description:

This is a bilateral, open label, dispensing study with subjects who have completed dual focus soft contact lens wear treatment for either 3 or 6 years and who are refit to Proclear 1-day lens for 1 year.


Recruitment information / eligibility

Status Completed
Enrollment 83
Est. completion date March 1, 2021
Est. primary completion date March 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 14 Years to 19 Years
Eligibility Inclusion Criteria: - Successfully completed the MIST-401 Parts 1 and 2 - Visual acuity (VA) with CLs better than +0.25 log MAR (>6/12 or >20/40) in both eyes - No ocular pathology or other contraindication to contact lens wear - Where applicable (dependent on local requirements), have: 1. read the Informed Assent 2. been given an explanation of the Informed Assent, 3. indicated an understanding of the Informed Assent and 4. signed the Informed Assent Form. Or 5. read the Informed Consent, 6. been given an explanation of the Informed Consent, 7. indicated an understanding of the Informed Consent and 8. signed the Informed Consent Form. - Where applicable (dependent on local requirements), have their parent or legal guardian: 1. read the Informed Consent, 2. been given an explanation of the Informed Consent, 3. indicated an understanding of the Informed Consent and 4. signed the Informed Consent Form. - Along with their parent or guardian (if applicable), be capable of comprehending the nature of the study, and be willing and able to adhere to the instructions set forth in this protocol. - Along with their parent or guardian (if applicable), agree to maintain the visit schedule and be able to keep all appointments as specified in the study protocol for the duration of the study. - Agree to wear the assigned contact lenses for a minimum of 10 hours per day, at least 6 days per week, for the duration of the study and to inform the study investigator if this schedule is interrupted. (Wearing time may be modified by the study staff for health reasons.) - Be in good general health, based on his/her and parent's/guardian's (if applicable) knowledge. - Have best-corrected visual acuity by manifest refraction of +0.10 logMAR (20/25 Snellen equivalent) or better in each eye. Exclusion Criteria: - Regular use of ocular medications (prescription or over-the-counter). - Current use of systemic medications which, in the investigators opinion, may significantly affect contact lens wear, tear film production, pupil size, accommodation or refractive state. - Pregnant or lactating or planning a pregnancy at the time of enrolment. - Known ocular or systemic disease such as, but not limited to: anterior uveitis or iritis, episcleritis or scleritis, glaucoma, Sjogren's syndrome, lupus erythematosus, scleroderma, or diabetes. - Any ocular, systemic or neuro-developmental conditions that in the investigators opinion, could influence refractive development. - Keratoconus or an irregular cornea. - Biomicroscope findings that would contraindicate contact lens wear including, but not limited to: 1. Any active anterior segment ocular disease that would contraindicate contact lens wear. 2. clinically significant (Grade 3 or 4) abnormalities of the anterior segment, lids, conjunctiva, sclera or associated structures. - The investigator for any reason considers that it is not in the best interest of the subject to participate in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Single Vision Soft Contact Lens
Subjects refit to Single Vision Soft Contact Lens for 1 year

Locations

Country Name City State
Canada University of Waterloo School of Optometry Waterloo Ontario
Portugal University of Minho Clinical & Experiment Optometry Research Lab Braga
Singapore National University of Singapore Faculty of Medicine Singapore
United Kingdom Aston University Ophthalmic Research Group Birmingham

Sponsors (2)

Lead Sponsor Collaborator
Coopervision, Inc. Visioncare Research Ltd.

Countries where clinical trial is conducted

Canada,  Portugal,  Singapore,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Spherical Equivalent Refractive Error (SERE) Change in spherical equivalent refractive error (SERE) relative to baseline (i.e., at end of dual focus soft contact lens wear treatment of either 3 or 6 years). Cycloplegic autorefraction was used to measure refractive error. 1 year
Primary Change in Axial Length (AL) Change in axial length (AL) relative to baseline (i.e., at end of dual focus soft contact lens wear treatment of either 3 or 6 years). Partial coherence interferometry was used to measure axial length. 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT04923841 - Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine N/A
Active, not recruiting NCT04080128 - Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control N/A
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Completed NCT04604405 - Effects of 650nm Low Energy Light on Human Retina and Choroid Microcirculation N/A
Recruiting NCT05594719 - The Effect of Sun-like Spectrum With Different Spectrum Composition on Retinal Blood Flow N/A
Completed NCT05594732 - The Effects of Different Outdoor Light Exposure Modes on Retinal Blood Flow N/A
Completed NCT04492397 - Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI) N/A
Completed NCT04536571 - Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses N/A
Completed NCT06046209 - Comparing a Monthly Replacement Lens Versus a Daily Disposable Lens N/A
Recruiting NCT06344572 - Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia Phase 3
Recruiting NCT05611294 - Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction N/A
Completed NCT05656885 - Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses N/A
Active, not recruiting NCT05534022 - Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression. N/A
Completed NCT03934788 - the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT03701516 - Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2 N/A
Completed NCT05538754 - Post-Market Evaluation of the EVO ICL N/A
Completed NCT03139201 - Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT02555722 - Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear N/A
Not yet recruiting NCT06009458 - Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear N/A
Recruiting NCT05548478 - Corneal Endothelial Cell Injury Induced by Mitomycin-C N/A